Durant, S. T., Zheng, L., Wang, Y., Chen, K., Zhang, L., Zhang, T., . . . Pass, M. (2018). The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv.
استشهاد بنمط شيكاغوDurant, Stephen T., et al. "The Brain-penetrant Clinical ATM Inhibitor AZD1390 Radiosensitizes and Improves Survival of Preclinical Brain Tumor Models." Sci Adv 2018.
MLA استشهادDurant, Stephen T., et al. "The Brain-penetrant Clinical ATM Inhibitor AZD1390 Radiosensitizes and Improves Survival of Preclinical Brain Tumor Models." Sci Adv 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.